CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 83 enrolled
Drug / intervention
Lumbar Plexus Blockade +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01286805
NCT01286805Phase 4Completed
CompareCT.gov

Lumbar Plexus Block for Postoperative Pain Control After Hip Arthroscopy. A Randomized Controlled Trial

Hospital for Special Surgery, New York·interventional·Posted Jan 31, 2011·Updated Jun 5, 2013

In Brief

A Phase 4 clinical trial evaluating Lumbar Plexus Blockade and Control for Postoperative Pain. Completed, enrolled 83 participants across 2 sites.

Detailed Summary

The purpose of this study is to determine whether the use of a lumbar plexus block for arthroscopic hip surgery is superior to oral and intravenous opioid pain medications alone in treating pain. In addition, the study will examine whether lumbar plexus blocks reduce the total amount of pain medication needed, and therefore reduce the side effects of these medicines and increase patient satisfaction. It is hypothesized that addition of the lumbar plexus block will significantly reduce patients' postoperative pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Pain
CountriesUnited States
CollaboratorsNew York Presbyterian Hospital

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 31, 2011
Enrollment StartMay 1, 2010
Primary CompletionOct 1, 2010
Study CompletionMay 1, 2011
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 15.4 years ago

Interventions

Lumbar Plexus Blockadeprocedure

The lumbar plexus block will be dosed with 30 milliliters of 0.25% bupivacaine with 1:200,000 epinephrine

Controlprocedure

The control group will receive only a combined spinal-epidural.